News Releases

LOUISVILLE SURGEONS PLAN UPDATE ON STATUS OF FIRST ABIOCOR PATIENT

(LOUISVILLE) - The University of Louisville surgeons who implanted the world's first totally implantable replacement heart in Bob Tools at Jewish Hospital on July 2 announced today that they will update the public on Mr. Tools' condition on Wednesday, November 14 at 2:00 p.m. EST.

Dr. Laman Gray reported a major setback for Mr. Tools, which "began with the onset of weakness in the right side of his body."

Additional details regarding the patients enrolled in the Jewish Hospital/University of Louisville AbioCor clinical trial will not be available until the news briefing.

Dr. Gray and Dr. Robert Dowling will give a full update on Mr. Tools' current diagnosis and prognosis tomorrow at 2:00 p.m. EST in the Conference Center atop the Rudd Heart and Lung Center on the Jewish Hospital campus.

The news conference will be up-linked live via satellite coordinates Ku-Band SBS 6, Transponder 7, Horizontal Frequency 11872 MHZ, 74 degrees West. The audio frequency is 6.20/6.80. The signal will be available from 2-3 p.m. (EST), Wednesday, November 14.

The news conference will also be web cast at www.heartpioneers.com. For future reference, the press conference will be archived on www.heartpioneers.com.

Printer friendly version (Adobe Acrobat Reader Required)